EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Platelet-activating factor (PAF) promotes immunosuppressive neutrophil differentiation within tumors

Ankit Dahal iD, Yeonsun Hong, Jocelyn S Mathew, Adam Geber, Sarah Eckl iD, Stephanie Renner, Cooper J Sailer iD, Allison T Ryan iD, Sana Mir iD, Kihong Lim iD, David C Linehan, Scott A Gerber und 1 weitere

Proceedings of the National Academy of Sciences · 27.08.2024 · 121 (35)

DOI: 10.1073/pnas.2406748121 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 23.08.2024. Verfasst von Ankit Dahal und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, David H. Smith Center for Vaccine Biology and Immunology, University of Rochester, Rochester, NY. Hauptthemen laut MEDLINE: Neutrophils, Cell Differentiation, Tumor Microenvironment, Platelet Activating Factor. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID), HHS | NIH | National Institute of General Medical Sciences (NIGMS), HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic inflammatory milieu in the tumor microenvironment (TME) leads to the recruitment and differentiation of myeloid-derived suppressor cells (MDSCs). Polymorphonuclear (PMN)-MDSCs, which are phenotypically and morphologically defined as a subset of neutrophils, cause major immune suppression in the TME, posing a significant challenge in the development of effective immunotherapies. Despite recent advances in our understanding of PMN-MDSC functions, the mechanism that gives rise to immunosuppressive neutrophils within the TME remains elusive. Both in vivo and in vitro, newly recruited neutrophils into the tumor sites remained activated and highly motile for several days and developed immunosuppressive phenotypes, as indicated by increased arginase 1 (Arg1) and dcTrail-R1 expression and suppressed anticancer CD8 T cell cytotoxicity. The strong suppressive function was successfully recapitulated by incubating naive neutrophils with cancer cell culture supernatant in vitro. Cancer metabolite secretome analyses of the culture supernatant revealed that both murine and human cancers released lipid mediators to induce the differentiation of immunosuppressive neutrophils. Liquid chromatography–mass spectrometry (LC-MS) lipidomic analysis identified platelet-activation factor (PAF; 1- O -alkyl-2-acetyl- sn -glycero-3-phosphocholine) as a common tumor-derived lipid mediator that induces neutrophil differentiation. Lysophosphatidylcholine acyltransferase 2 (LPCAT2), the PAF biosynthetic enzyme, is up-regulated in human pancreatic ductal adenocarcinoma (PDAC) and shows an unfavorable correlation with patient survival across multiple cancer types. Our study identifies PAF as a lipid-driven mechanism of MDSC differentiation in the TME, providing a potential target for cancer immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeutrophilsCell DifferentiationTumor MicroenvironmentPlatelet Activating FactorMyeloid-Derived Suppressor CellsHumansAnimalsMiceCell Line, TumorCD8-Positive T-LymphocytesMice, Inbred C57BL

Stichwörter der Autor:innen

CancerMDSCmyeloid cellsneutrophiltumor microenvironment

Substanzen

Platelet Activating Factor

Autor:innen und Institutionen

  • Department of Microbiology and Immunology, David H. Smith Center for Vaccine Biology and Immunology, University of Rochester, Rochester, NY.
  • Department of Pathology, University of Rochester Medical Center, Rochester, NY.
  • Department of Surgery, University of Rochester Medical Center, Rochester, NY.
  • Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY.

ORCID-Profile: Ankit Dahal, Sarah Eckl, Cooper J Sailer, Allison T Ryan, Sana Mir, Kihong Lim, Minsoo Kim

Förderung

  • HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
  • HHS | NIH | National Institute of General Medical Sciences (NIGMS)
  • HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI)
  • NHLBI NIH HHS
  • NIGMS NIH HHS

Zitieren

APA

Dahal, A., Hong, Y., Mathew, J. S., Geber, A., Eckl, S., Renner, S., Sailer, C. J., Ryan, A. T., Mir, S., Lim, K., Linehan, D. C., Gerber, S. A., & Kim, M. (2024). Platelet-activating factor (PAF) promotes immunosuppressive neutrophil differentiation within tumors. Proceedings of the National Academy of Sciences, 121(35). https://doi.org/10.1073/pnas.2406748121

Vancouver

Dahal A, Hong Y, Mathew JS, Geber A, Eckl S, Renner S, et al. Platelet-activating factor (PAF) promotes immunosuppressive neutrophil differentiation within tumors. Proceedings of the National Academy of Sciences. 2024;121(35). doi:10.1073/pnas.2406748121

BibTeX
@article{Dahal2024,
  author = {Dahal, Ankit and Hong, Yeonsun and Mathew, Jocelyn S and Geber, Adam and Eckl, Sarah and Renner, Stephanie and Sailer, Cooper J and Ryan, Allison T and Mir, Sana and Lim, Kihong and Linehan, David C and Gerber, Scott A and Kim, Minsoo},
  title = {Platelet-activating factor (PAF) promotes immunosuppressive neutrophil differentiation within tumors},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2024},
  volume = {121},
  number = {35},
  doi = {10.1073/pnas.2406748121}
}
Kostenlos starten →